---
title: "CJC-1295 Traveling: How to Store and Inject | HealthRX.com"
description: "A complete clinical guide to traveling while on CJC-1295 modified GRF: storage temperatures, TSA rules, injection timing across time zones, and real-world…"
url: https://healthrx.com/lifestyle-cjc-1295/travel
publisher: HealthRX.com
---


HealthRX.com

Traveling with CJC-1295 has no approved guidance

[Print or save as PDF](https://healthrx.com/printables/lifestyle-cjc-1295/travel?print=1)

Key numbers

- 9 to 11 days How long IGF-I stayed raised after one injection in healthy adults Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/16352683/), as cited Nov 7, 2026
- 30 to 250 mcg/kg Doses given in the human trials, which are not recommended doses Source: [fda.gov](https://www.fda.gov/media/183819/download), as cited Nov 7, 2026
- 63% versus 14% Headache in treated subjects versus placebo subjects in the trials Source: [fda.gov](https://www.fda.gov/media/183819/download), as cited Nov 7, 2026

HealthRX.com quick answer. CJC-1295 is not an FDA-approved drug, and FDA found no approved product containing any form of it in the twelve countries it searched or authorised by the European Medicines Agency [1]. That finding does not by itself set the rules for carrying it across a border, and no storage or time-zone dosing guidance exists for it, because it has never been approved.

At a glance

- Approval / Not FDA-approved; no approved product in the twelve countries FDA searched [1]
- Class / Long-acting growth hormone-releasing hormone analogue; the DAC form binds albumin [1][2]
- Human studies / Three published, all of the DAC form, all in healthy volunteers [1]
- Half-life / 5.8 to 8.1 days after one subcutaneous injection [3]
- Reactions / Injection-site reactions about 70% in study 1; headache 63% versus 14% on placebo [1][3]
- Sport / WADA names CJC-1295 in S2.2.4; prohibited at all times [4]

## Approval status across borders

FDA's December 2024 review looked for an approved product containing any form of CJC-1295 in Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Italy, Japan, Norway, Spain and the United Kingdom, and at the European Medicines Agency, and found none [1]. Two forms exist: CJC-1295, a 29-amino-acid GHRH analogue, and CJC-1295 DAC, the same peptide with an extra maleimidopropionic acid-lysine unit that lets it bind blood albumin and last much longer [1][2]. FDA noted that CJC-1295 products sold online are mostly labelled research use only, including blends with ipamorelin and GHRPs, and research-use-only products are not FDA-approved drugs [1]. FDA's Pharmacy Compounding Advisory Committee voted 0 yes and 13 no on the free base, 1 yes and 12 no on the acetate, and 0 yes and 13 no on each of the three DAC forms [5].

Questions worth asking

Choose the questions you want to keep Does my prescriber or pharmacy have a written storage plan for travel? How should a vial be kept cool during a long flight or road trip? What should I do if a vial looks cloudy or clumped before I inject? Can you confirm the product source and whether it is labelled for human use? If I cross time zones, how should my prescriber help me plan dose timing?

## Studies FDA identified and which form they used

FDA identified three published human studies, all of the DAC form and all in healthy volunteers: Teichman 2006, Ionescu and Frohman 2006 and Sackmann-Sala 2009 [1]. No trial tested a version sold as CJC-1295 without DAC, and none tested people with a disease [1]. Teichman 2006 ran two randomised, placebo-controlled, double-blind, ascending-dose trials of 28 and 49 days in healthy adults aged 21 to 61, one using single subcutaneous doses and one using two or three weekly or biweekly doses [3]. After a single injection the estimated half-life was 5.8 to 8.1 days, mean GH rose 2- to 10-fold for 6 days or more and IGF-I rose 1.5- to 3-fold for 9 to 11 days [3]. Doses studied were about 30 to 250 mcg/kg, which are not recommended doses [1][3].

## What showed up in the trials

Injection-site reactions occurred in about 70% of treated subjects in study 1 and in all treated subjects in study 2; headache in 63% versus 14% on placebo; and flushing, warmth and transient low blood pressure in about 30% of treated subjects in study 1, with most events more common at the higher doses [1][3]. FDA cited approved growth hormone labels for the risks of raising GH and IGF-I, namely glucose intolerance and diabetes, fluid retention and tumour growth concerns, and said the human studies were short, small and mostly single-dose, so long-term safety is unknown [1]. ConjuChem withdrew CJC-1295 DAC from clinical trials in 2006 after a participant in a phase 2 trial in HIV lipodystrophy (192 enrolled) died; the data were never published, so a causal link is neither shown nor excluded [1].

## Timing and time zones

There is no approved dosing schedule for CJC-1295. In the human studies the DAC form was given as single injections or as weekly or every-2-week doses, and after one injection GH stayed raised for 6 days or more and IGF-I for 9 to 11 days [1][3].

## If you compete while travelling

WADA's 2026 Prohibited List names CJC-1295 and CJC-1293 in S2.2.4 as growth hormone-releasing hormone analogues, prohibited at all times, in and out of competition, and the 2027 List names it too [4][6].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. According to the article, what does the extra maleimidopropionic acid-lysine unit do in CJC-1295 DAC?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Try the tool

Peptide reconstitution math

Calculate mass per volume in mg/mL and mcg/mL, and see how concentration depends on the final solution volume.

[Open the concentration calculator](https://healthrx.com/tools/peptide-reconstitution)

Printable question sheet

CJC peptide questions to bring to a prescriber or pharmacist

Use this sheet before a trip, or before a visit about the CJC peptide. Fill it in by hand, take it to your prescriber or pharmacist, or keep it at home with your travel papers.

[Open the fill-in sheet](https://healthrx.com/printables/lifestyle-cjc-1295/travel) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Can I take CJC-1295 through customs in another country?

FDA found no approved product containing any form of CJC-1295 in Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Italy, Japan, Norway, Spain or the United Kingdom, and none authorised by the European Medicines Agency [1]. That finding does not establish any country's import or customs rules for it. FDA noted that products sold online are mostly labelled research use only, and such products are not approved drugs [1].

How long does one CJC-1295 injection last?

In Teichman 2006 the estimated half-life after one subcutaneous injection of the DAC form was 5.8 to 8.1 days; mean plasma GH rose 2- to 10-fold for 6 days or more and IGF-I rose 1.5- to 3-fold for 9 to 11 days, and after multiple doses IGF-I stayed above baseline for up to 28 days [3].

Can I compete in sport while using CJC-1295?

No. WADA's 2026 Prohibited List names CJC-1295 in S2.2.4 as a growth hormone-releasing hormone analogue, prohibited at all times, in and out of competition, and the 2027 List names it as well [4][6].

References

Show all 6 references Hide references

1. [U.S. Food and Drug Administration](https://www.fda.gov/media/183819/download).
2. Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, et al. [Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog](https://pubmed.ncbi.nlm.nih.gov/15817669/). Endocrinology. 2005;146(7):3052-8.
3. Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. [Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults](https://pubmed.ncbi.nlm.nih.gov/16352683/). J Clin Endocrinol Metab. 2006;91(3):799-805.
4. [World Anti-Doping Agency](https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf).
5. [U.S. Food and Drug Administration](https://www.fda.gov/media/185642/download).
6. [World Anti-Doping Agency](https://www.wada-ama.org/sites/default/files/2026-09/2027list_en_final_tracked_changes_26_august_2026.pdf).

Next in this cluster

Related reading

- [peptides performance BPC-157 vs TB-500](https://healthrx.com/compare-peptides-performance/bpc-157-vs-tb-500--cost-access)
- [semaglutide Cagrilintide and CagriSema](https://healthrx.com/glp-1/cagrilintide)
- [cjc 1295 modified grf CJC-1295 for Fat Loss: What the Evidence Actually Shows](https://healthrx.com/off-label-cjc-1295/fat-loss--evidence-summary)
- [cjc 1295 modified grf CJC-1295 for Longevity](https://healthrx.com/off-label-cjc-1295/longevity--evidence-summary)
- [cjc 1295 modified grf CJC-1295 for Longevity](https://healthrx.com/off-label-cjc-1295/longevity--monitoring)
- [cjc 1295 modified grf CJC-1295 for Recovery: Off-Label Evidence Summary](https://healthrx.com/off-label-cjc-1295/recovery--evidence-summary)
- [cjc 1295 modified grf CJC-1295 for Recovery](https://healthrx.com/off-label-cjc-1295/recovery--monitoring)
- [cjc 1295 modified grf CJC-1295 for Sleep: Off-Label Evidence Summary](https://healthrx.com/off-label-cjc-1295/sleep--evidence-summary)
- [cjc 1295 Is CJC-1295 Legal in Alabama? Federal and State Framework Explained](https://healthrx.com/peptide-legal-cjc-1295/alabama--legal-status)
- [cjc 1295 CJC-1295 Legal Status: FDA Approval and Compounding Rules](https://healthrx.com/peptide-legal-cjc-1295/california--legal-status)
- [cjc 1295 CJC-1295 Compounding Pharmacy Quality Red Flags to Avoid](https://healthrx.com/peptide-pharmacy-cjc-1295/quality-red-flags)
- [cjc 1295 modified grf CJC-1295 and Estradiol HRT Interaction](https://healthrx.com/interactions-cjc-1295/with-hrt-estradiol)
- [cjc 1295 vs egrifta tesamorelin CJC-1295 vs Egrifta (Tesamorelin)](https://healthrx.com/compare-peptides-growth-hormone/cjc-1295-vs-tesamorelin--cost-access)
- [cjc 1295 modified grf CJC-1295 and Acetaminophen Interaction](https://healthrx.com/interactions-cjc-1295/with-acetaminophen)

![cjc-1295 traveling: insulated case with sealed sample tubes and thermometer](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/lifestyle-cjc-1295/travel.webp)

Temperature-controlled transport of research samples illustrates why storage and border rules matter when moving this peptide.

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
